Session Chair Profile
M.D., Chief Executive Officer and President of GeneCentric Diagnostics
Dr. Lai-Goldman is the Chief Executive Officer and co-founder of GeneCentric Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing assays that enable oncologists and their patients to make informed, individualized, treatment decisions. She is also the managing partner of Personalized Science, LLC, a consulting company that is focused on innovative diagnostics for patients’ unmet clinical needs. Dr. Lai-Goldman currently serves on the board of directors of West Pharmaceutical Services, Inc., a provider of drug administration systems, and Qvella Corporation, a privately-held molecular diagnostics company. She is also a venture partner with Hatteras Venture Partners, a position she has held since August 2011. From 1990 to December 2008, Dr. Lai-Goldman served in various roles at Laboratory Corporation of America Holdings and its predecessor company, Roche Biomedical Laboratories, including Executive Vice President, Chief Medical Officer, and Chief Scientific Officer. Dr. Lai-Goldman received her medical degree from Columbia University College of Physicians and Surgeons.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: Precision Medicine requires the cooperation of two major stakeholders with distinctly different businesses, Pharmaceutical and Diagnostics, working together to achieve the approval of drugs with diagnostics. Using specific case studies, this session will debate the often “opposing sides” of co-development, with the goal of maximizing communication, understanding and impact for future projects.